🚀 VC round data is live in beta, check it out!

Vuno Valuation Multiples

Discover revenue and EBITDA valuation multiples for Vuno and similar public comparables like SANUWAVE Health, Pro-Dex, Detection Technology, Deltex Medical Group and more.

Vuno Overview

About Vuno

Vuno Inc is engaged in the business of manufacturing medical devices and equipment. The company develops and markets bone age testing equipment, brain quantification medical device, X-ray reading aid solutions, imaging devices, and other related devices.


Founded

2014

HQ

South Korea

Employees

N/A

Website

vuno.co

Financials (FY)

Revenue: $24M
EBITDA: ($3M)

EV

$159M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Vuno Financials

Vuno reported last fiscal year revenue of $24M and negative EBITDA of ($3M).

In the same fiscal year, Vuno generated $23M in gross profit, ($3M) in EBITDA losses, and had net loss of ($4M).

Revenue (LTM)


Vuno P&L

In the most recent fiscal year, Vuno reported revenue of $24M and EBITDA of ($3M).

Vuno expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Vuno forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$24MXXXXXXXXX
Gross ProfitXXX$23MXXXXXXXXX
Gross MarginXXX98%XXXXXXXXX
EBITDAXXX($3M)XXXXXXXXX
EBITDA MarginXXX(11%)XXXXXXXXX
EBIT MarginXXX(14%)XXXXXXXXX
Net ProfitXXX($4M)XXXXXXXXX
Net MarginXXX(17%)XXXXXXXXX
Net Debt$972KXXXXXXXXX

Financial data powered by Morningstar, Inc.

Vuno Stock Performance

Vuno has current market cap of $175M, and enterprise value of $159M.

Market Cap Evolution


Vuno's stock price is $12.48.

See Vuno trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$159M$175M0.0%XXXXXXXXX$-0.28

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Vuno Valuation Multiples

Vuno trades at 6.7x EV/Revenue multiple, and (63.2x) EV/EBITDA.

See valuation multiples for Vuno and 15K+ public comps

EV / Revenue (LTM)


Vuno Financial Valuation Multiples

As of April 20, 2026, Vuno has market cap of $175M and EV of $159M.

Equity research analysts estimate Vuno's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Vuno has a P/E ratio of (44.3x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$175MXXX$175MXXXXXXXXX
EV (current)$159MXXX$159MXXXXXXXXX
EV/RevenueXXX6.7xXXXXXXXXX
EV/EBITDAXXX(63.2x)XXXXXXXXX
EV/EBITXXX(47.2x)XXXXXXXXX
EV/Gross ProfitXXX6.8xXXXXXXXXX
P/EXXX(44.3x)XXXXXXXXX
EV/FCFXXX(40.5x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Vuno Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Vuno Margins & Growth Rates

Vuno's revenue in the last fiscal year grew by 35%.

See operational valuation multiples for Vuno and other 15K+ public comps

Vuno Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX35%XXXXXXXXX
EBITDA MarginXXX(11%)XXXXXXXXX
EBITDA GrowthXXX(66%)XXXXXXXXX
S&M Expenses to RevenueXXX46%XXXXXXXXX
G&A Expenses to RevenueXXX8%XXXXXXXXX
R&D Expenses to RevenueXXX17%XXXXXXXXX
Opex to RevenueXXX112%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Vuno Public Comps

See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
VunoXXXXXXXXXXXXXXXXXX
SANUWAVE HealthXXXXXXXXXXXXXXXXXX
Pro-DexXXXXXXXXXXXXXXXXXX
Detection TechnologyXXXXXXXXXXXXXXXXXX
Deltex Medical GroupXXXXXXXXXXXXXXXXXX
TeraView HoldingsXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Vuno M&A Activity

Vuno acquired XXX companies to date.

Last acquisition by Vuno was on XXXXXXXX, XXXXX. Vuno acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Vuno

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Vuno Investment Activity

Vuno invested in XXX companies to date.

Vuno made its latest investment on XXXXXXXX, XXXXX. Vuno invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Vuno

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Vuno

When was Vuno founded?Vuno was founded in 2014.
Where is Vuno headquartered?Vuno is headquartered in South Korea.
Is Vuno publicly listed?Yes, Vuno is a public company listed on Korea Exchange.
What is the stock symbol of Vuno?Vuno trades under 338220 ticker.
When did Vuno go public?Vuno went public in 2021.
Who are competitors of Vuno?Vuno main competitors are SANUWAVE Health, Pro-Dex, Detection Technology, Deltex Medical Group.
What is the current market cap of Vuno?Vuno's current market cap is $175M.
What is the current revenue of Vuno?Vuno's last fiscal year revenue is $24M.
What is the current EV/Revenue multiple of Vuno?Current revenue multiple of Vuno is 6.7x.
Is Vuno profitable?No, Vuno is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial